questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Acides nucléiques
ARN
ARN ribosomique
ARN ribosomique 18S
ARN ribosomique 18S : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ARN ribosomique 18S : Questions médicales les plus fréquentes",
"headline": "ARN ribosomique 18S : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ARN ribosomique 18S : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ARN ribosomique 18S"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "ARN ribosomique",
"url": "https://questionsmedicales.fr/mesh/D012335",
"about": {
"@type": "MedicalCondition",
"name": "ARN ribosomique",
"code": {
"@type": "MedicalCode",
"code": "D012335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.735.686"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "ARN ribosomique 18S",
"alternateName": "RNA, Ribosomal, 18S",
"code": {
"@type": "MedicalCode",
"code": "D012337",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harutaro Kenmotsu",
"url": "https://questionsmedicales.fr/author/Harutaro%20Kenmotsu",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Yuu Hirose",
"url": "https://questionsmedicales.fr/author/Yuu%20Hirose",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Toshihiko Eki",
"url": "https://questionsmedicales.fr/author/Toshihiko%20Eki",
"affiliation": {
"@type": "Organization",
"name": "Molecular Genetics Laboratory, Department of Applied Chemistry and Life Science, Toyohashi University of Technology, Toyohashi, Aichi, Japan."
}
},
{
"@type": "Person",
"name": "Ludivine Wacheul",
"url": "https://questionsmedicales.fr/author/Ludivine%20Wacheul",
"affiliation": {
"@type": "Organization",
"name": "RNA Molecular Biology, ULB Cancer Research Center (U-CRC), Centre for Microscopy and Molecular Imaging (CMMI), Fonds de la Recherche Scientifique (F.R.S.-FNRS), Université Libre de Bruxelles (ULB), Charleroi-Gosselies, Belgium."
}
},
{
"@type": "Person",
"name": "Anil Kumar Nehra",
"url": "https://questionsmedicales.fr/author/Anil%20Kumar%20Nehra",
"affiliation": {
"@type": "Organization",
"name": "Department of Veterinary Parasitology, Lala Lajpat Rai University of Veterinary and Animal Sciences, 125004, Hisar, Haryana, India. anilnehra15@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39478631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13014-024-02541-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "EBV-Associated Gastric Cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.",
"datePublished": "2024-04-01",
"url": "https://questionsmedicales.fr/article/38685845",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2024.28"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Automation Workflow for High-Throughput Manufacturing and Analysis of Scaffold-Supported 3D Tissue Arrays.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37086259",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adhm.202202422"
}
},
{
"@type": "ScholarlyArticle",
"name": "Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37697694",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cjp2.342"
}
},
{
"@type": "ScholarlyArticle",
"name": "DNA quality evaluation of formalin-fixed paraffin-embedded heart tissue for DNA methylation array analysis.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36737451",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-29120-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ARN",
"item": "https://questionsmedicales.fr/mesh/D012313"
},
{
"@type": "ListItem",
"position": 5,
"name": "ARN ribosomique",
"item": "https://questionsmedicales.fr/mesh/D012335"
},
{
"@type": "ListItem",
"position": 6,
"name": "ARN ribosomique 18S",
"item": "https://questionsmedicales.fr/mesh/D012337"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ARN ribosomique 18S - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ARN ribosomique 18S",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ARN ribosomique 18S",
"description": "Comment détecte-t-on l'ARN ribosomique 18S ?\nQuels tests sont utilisés pour l'analyse de l'ARN 18S ?\nL'ARN 18S est-il spécifique à certaines espèces ?\nPeut-on quantifier l'ARN 18S ?\nQuels échantillons sont nécessaires pour l'analyse de l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ARN ribosomique 18S",
"description": "Quels symptômes sont liés à des anomalies de l'ARN 18S ?\nL'ARN 18S affecte-t-il la santé cellulaire ?\nDes infections peuvent-elles influencer l'ARN 18S ?\nY a-t-il des signes de cancer liés à l'ARN 18S ?\nL'ARN 18S est-il impliqué dans des maladies neurodégénératives ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ARN ribosomique 18S",
"description": "Comment prévenir les anomalies de l'ARN 18S ?\nL'éducation génétique peut-elle aider à prévenir des maladies liées à l'ARN 18S ?\nDes dépistages réguliers sont-ils recommandés ?\nLes vaccinations influencent-elles l'ARN 18S ?\nY a-t-il des recommandations alimentaires pour la santé de l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ARN ribosomique 18S",
"description": "Quels traitements ciblent l'ARN 18S ?\nL'ARN 18S peut-il être utilisé en thérapie ?\nComment les antibiotiques affectent-ils l'ARN 18S ?\nY a-t-il des traitements pour les anomalies de l'ARN 18S ?\nLes thérapies ciblées peuvent-elles influencer l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ARN ribosomique 18S",
"description": "Quelles complications peuvent survenir avec des anomalies de l'ARN 18S ?\nL'ARN 18S est-il lié à des complications respiratoires ?\nDes complications neurologiques peuvent-elles être liées à l'ARN 18S ?\nL'ARN 18S peut-il être impliqué dans des complications cancéreuses ?\nQuelles sont les complications métaboliques liées à l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ARN ribosomique 18S",
"description": "Quels facteurs de risque sont associés à des anomalies de l'ARN 18S ?\nL'exposition à des toxines affecte-t-elle l'ARN 18S ?\nLe stress oxydatif influence-t-il l'ARN 18S ?\nDes habitudes alimentaires peuvent-elles influencer l'ARN 18S ?\nL'âge est-il un facteur de risque pour l'ARN 18S ?",
"url": "https://questionsmedicales.fr/mesh/D012337?mesh_terms=Tissue+Array+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on l'ARN ribosomique 18S ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ARN 18S est souvent détecté par PCR ou séquençage pour identifier des organismes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'analyse de l'ARN 18S ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse et l'hybridation pour évaluer la qualité de l'ARN."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il spécifique à certaines espèces ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'ARN 18S présente des variations spécifiques aux espèces, utile pour l'identification."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier l'ARN 18S ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la quantification se fait par RT-qPCR pour mesurer l'expression génique."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont nécessaires pour l'analyse de l'ARN 18S ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de tissus, cellules ou fluides biologiques sont requis pour l'analyse."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des anomalies de l'ARN 18S ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies peuvent entraîner des troubles de croissance ou des maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'ARN 18S affecte-t-il la santé cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'ARN 18S peuvent perturber la synthèse protéique et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Des infections peuvent-elles influencer l'ARN 18S ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent altérer l'expression de l'ARN 18S, affectant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de cancer liés à l'ARN 18S ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux d'ARN 18S modifiés peuvent être associés à certains types de cancer."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il impliqué dans des maladies neurodégénératives ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'ARN 18S et certaines maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies de l'ARN 18S ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition et un mode de vie sain peuvent aider à prévenir les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique peut-elle aider à prévenir des maladies liées à l'ARN 18S ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation génétique permet de mieux comprendre les risques et de prendre des mesures préventives."
}
},
{
"@type": "Question",
"name": "Des dépistages réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à identifier précocement des anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles l'ARN 18S ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations peuvent indirectement influencer l'expression de l'ARN 18S en renforçant l'immunité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires pour la santé de l'ARN 18S ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en acides gras oméga-3 et en antioxydants peut soutenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'ARN 18S ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments peuvent cibler l'expression de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "L'ARN 18S peut-il être utilisé en thérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches thérapeutiques exploitent l'ARN 18S pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment les antibiotiques affectent-ils l'ARN 18S ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antibiotiques ciblent les ribosomes, affectant ainsi l'ARN 18S et la synthèse protéique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour les anomalies de l'ARN 18S ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements spécifiques peuvent être développés pour corriger les anomalies de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées peuvent-elles influencer l'ARN 18S ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies ciblées peuvent moduler l'expression de l'ARN 18S dans certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies de l'ARN 18S ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques et des maladies héréditaires."
}
},
{
"@type": "Question",
"name": "L'ARN 18S est-il lié à des complications respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien potentiel entre l'ARN 18S et certaines infections respiratoires."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques peuvent-elles être liées à l'ARN 18S ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de l'ARN 18S peuvent être associées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'ARN 18S peut-il être impliqué dans des complications cancéreuses ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'ARN 18S sont souvent observés dans divers types de cancers."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications métaboliques liées à l'ARN 18S ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de l'ARN 18S peuvent entraîner des déséquilibres métaboliques et des syndromes."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à des anomalies de l'ARN 18S ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et nutritionnels peuvent influencer l'ARN 18S."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle l'ARN 18S ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut altérer l'expression de l'ARN 18S et causer des dommages."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif influence-t-il l'ARN 18S ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut affecter la stabilité et l'expression de l'ARN 18S."
}
},
{
"@type": "Question",
"name": "Des habitudes alimentaires peuvent-elles influencer l'ARN 18S ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affecter l'expression de l'ARN 18S et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour l'ARN 18S ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner des modifications de l'expression de l'ARN 18S."
}
}
]
}
]
}
Head and neck squamous cell carcinoma (HNSCC) negative for Human Papillomavirus (HPV) has remained a difficult to treat entity, whereas tumors positive for HPV are characterized by radiosensitivity an...
A tissue microarray of a single center HNSCC cohort was stained for ATM, DNA-PKcs and Ku80 and the expression scored based on staining intensity and the percentages of tumor cells stained. Scores were...
Samples from 427 HNSCC patients yielded interpretable stainings and were scored following an established algorithm. The majority of tumors showed strong expression of both NHEJ factors, whereas the ex...
Our data suggest that HPV-negative HNSCC with particularly low Ku80 expression represent a highly radiosensitive subpopulation. Confirmation in independent cohorts is required....
Gastric cancer is the fourth leading cause of cancer-related deaths in the world. The identification of gastric cancer subtypes related to recognizable microbial agents may play a pivotal role in the ...
Paraffin blocks of 682 cases of various types of gastric cancer from Tehran, South and North areas of Iran were collected. Twelve tissue microarray (TMA) blocks were constructed from these blocks. Loc...
Fourteen out of 682 cases (2.1%) of gastric adenocarcinoma were EBER-positive. EBER was positive in 8 out of 22 (36.4%) of medullary carcinomas and 6 out of 660 (0.9%) of non-medullary type, which was...
EBV-associated gastric adenocarcinoma has a low prevalence in Iran. This finding can be due to epidemiologic differences in risk factors and exposures, and the low number of gastric medullary carcinom...
Patient-derived organoids have emerged as a useful tool to model tumour heterogeneity. Scaling these complex culture models while enabling stratified analysis of different cellular sub-populations, ho...
Multiplex immunofluorescence (mIF) imaging can provide comprehensive quantitative and spatial information for multiple immune markers for tumour immunoprofiling. However, application at scale to clini...
Archived formalin-fixed and paraffin-embedded (FFPE) heart tissue from autopsied individuals represents an important resource for investigating the DNA methylation of heart tissue of deceased individu...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human malignancies. Tissue microarrays (TMA) are an established method of high throughput biomarker interrogation in tissues but ...
The knowledge of the exact oxygen partial pressure in tissue is crucial for patient care and in the treatment of ischemic medical conditions. However, current methods to assess oxygen partial pressure...
Blood loss by hemorrhaging wounds accounts for over one-third of ∼5 million trauma fatalities worldwide every year. If not controlled in a timely manner, exsanguination can take lives within a few min...
Lung cancer is a fatal disease that kills approximately 85% of those diagnosed with it. In recent years, advances in medical imaging have greatly improved the acquisition, storage, and visualization o...
Develop a computer-aided diagnostic system to detect lung cancer early by segmenting tumor and non-tumor tissue on Tissue Micro Array Analysis (TMA) histopathological images....
The prototype computer-aided diagnostic system was developed to segment tumor areas, non-tumor areas, and fundus on TMA histopathological images....
The system achieved an average accuracy of 83.4% and an F-measurement of 84.4% in segmenting tumor and non-tumor tissue....
The computer-aided diagnostic system provides a second diagnostic opinion to specialists, allowing for more precise diagnoses and more appropriate treatments for lung cancer....
Serial assessment of the biomechanical properties of tissues can be used to aid the early detection and management of pathophysiological conditions, to track the evolution of lesions and to evaluate t...